S&P 500   3,853.07 (+0.03%)
DOW   31,176.01 (-0.04%)
QQQ   326.36 (+0.80%)
AAPL   136.87 (+3.67%)
MSFT   224.97 (+0.28%)
FB   272.87 (+2.02%)
GOOGL   1,884.15 (+0.22%)
AMZN   3,306.99 (+1.34%)
TSLA   844.99 (-0.64%)
NVDA   554.70 (+3.75%)
BABA   260.00 (-2.07%)
CGC   33.56 (-0.21%)
GE   11.07 (-2.81%)
MU   85.01 (+1.81%)
AMD   91.53 (+3.13%)
NIO   58.34 (+1.09%)
T   28.83 (-0.45%)
F   11.53 (+6.17%)
ACB   11.17 (-3.21%)
BA   207.41 (-1.91%)
DIS   171.28 (-1.36%)
NFLX   579.84 (-1.11%)
GILD   66.98 (-1.49%)
S&P 500   3,853.07 (+0.03%)
DOW   31,176.01 (-0.04%)
QQQ   326.36 (+0.80%)
AAPL   136.87 (+3.67%)
MSFT   224.97 (+0.28%)
FB   272.87 (+2.02%)
GOOGL   1,884.15 (+0.22%)
AMZN   3,306.99 (+1.34%)
TSLA   844.99 (-0.64%)
NVDA   554.70 (+3.75%)
BABA   260.00 (-2.07%)
CGC   33.56 (-0.21%)
GE   11.07 (-2.81%)
MU   85.01 (+1.81%)
AMD   91.53 (+3.13%)
NIO   58.34 (+1.09%)
T   28.83 (-0.45%)
F   11.53 (+6.17%)
ACB   11.17 (-3.21%)
BA   207.41 (-1.91%)
DIS   171.28 (-1.36%)
NFLX   579.84 (-1.11%)
GILD   66.98 (-1.49%)
S&P 500   3,853.07 (+0.03%)
DOW   31,176.01 (-0.04%)
QQQ   326.36 (+0.80%)
AAPL   136.87 (+3.67%)
MSFT   224.97 (+0.28%)
FB   272.87 (+2.02%)
GOOGL   1,884.15 (+0.22%)
AMZN   3,306.99 (+1.34%)
TSLA   844.99 (-0.64%)
NVDA   554.70 (+3.75%)
BABA   260.00 (-2.07%)
CGC   33.56 (-0.21%)
GE   11.07 (-2.81%)
MU   85.01 (+1.81%)
AMD   91.53 (+3.13%)
NIO   58.34 (+1.09%)
T   28.83 (-0.45%)
F   11.53 (+6.17%)
ACB   11.17 (-3.21%)
BA   207.41 (-1.91%)
DIS   171.28 (-1.36%)
NFLX   579.84 (-1.11%)
GILD   66.98 (-1.49%)
S&P 500   3,853.07 (+0.03%)
DOW   31,176.01 (-0.04%)
QQQ   326.36 (+0.80%)
AAPL   136.87 (+3.67%)
MSFT   224.97 (+0.28%)
FB   272.87 (+2.02%)
GOOGL   1,884.15 (+0.22%)
AMZN   3,306.99 (+1.34%)
TSLA   844.99 (-0.64%)
NVDA   554.70 (+3.75%)
BABA   260.00 (-2.07%)
CGC   33.56 (-0.21%)
GE   11.07 (-2.81%)
MU   85.01 (+1.81%)
AMD   91.53 (+3.13%)
NIO   58.34 (+1.09%)
T   28.83 (-0.45%)
F   11.53 (+6.17%)
ACB   11.17 (-3.21%)
BA   207.41 (-1.91%)
DIS   171.28 (-1.36%)
NFLX   579.84 (-1.11%)
GILD   66.98 (-1.49%)
Log in
NASDAQ:FWP

Forward Pharma A/S Stock Forecast, Price & News

$6.58
+0.03 (+0.46 %)
(As of 01/21/2021 12:00 AM ET)
Add
Compare
Today's Range
$6.55
Now: $6.58
$6.71
50-Day Range
$6.51
MA: $7.19
$8.05
52-Week Range
$4.61
Now: $6.58
$12.72
Volume12,482 shs
Average Volume37,437 shs
Market Capitalization$44.68 million
P/E RatioN/A
Dividend YieldN/A
Beta1.85
Forward Pharma A/S, a biopharmaceutical company, focuses on developing proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. The company was founded in 2005 and is headquartered in Copenhagen, Denmark.
Forward Pharma A/S logo

MarketRank

Overall MarketRank

0.69 out of 5 stars

Medical Sector

1211th out of 1,926 stocks

Pharmaceutical Preparations Industry

557th out of 773 stocks

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:FWP
CUSIPN/A
Phone0114533444242
Employees5

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$11.42 per share

Profitability

Miscellaneous

Market Cap$44.68 million
Next Earnings Date4/23/2021 (Estimated)
OptionableNot Optionable
$6.58
+0.03 (+0.46 %)
(As of 01/21/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive FWP News and Ratings via Email

Sign-up to receive the latest news and ratings for FWP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Forward Pharma A/S (NASDAQ:FWP) Frequently Asked Questions

How has Forward Pharma A/S's stock been impacted by Coronavirus?

Forward Pharma A/S's stock was trading at $5.55 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, FWP stock has increased by 18.6% and is now trading at $6.58.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than Forward Pharma A/S?

Wall Street analysts have given Forward Pharma A/S a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Forward Pharma A/S wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Doug Parker's approval rating as Forward Pharma A/S's CEO?

1,448 employees have rated Forward Pharma A/S CEO Doug Parker on Glassdoor.com. Doug Parker has an approval rating of 60% among Forward Pharma A/S's employees. This puts Doug Parker in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

When is Forward Pharma A/S's next earnings date?

Forward Pharma A/S is scheduled to release its next quarterly earnings announcement on Friday, April 23rd 2021.
View our earnings forecast for Forward Pharma A/S
.

How were Forward Pharma A/S's earnings last quarter?

Forward Pharma A/S (NASDAQ:FWP) issued its quarterly earnings results on Thursday, September, 1st. The biotechnology company reported ($0.32) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.26) by $0.06.
View Forward Pharma A/S's earnings history
.

Are investors shorting Forward Pharma A/S?

Forward Pharma A/S saw a decrease in short interest in the month of December. As of December 31st, there was short interest totaling 4,700 shares, a decrease of 66.9% from the December 15th total of 14,200 shares. Based on an average trading volume of 30,300 shares, the short-interest ratio is currently 0.2 days.
View Forward Pharma A/S's Short Interest
.

Who are some of Forward Pharma A/S's key competitors?

What other stocks do shareholders of Forward Pharma A/S own?

Who are Forward Pharma A/S's key executives?

Forward Pharma A/S's management team includes the following people:
  • Mr. Florian Schönharting, Co-Founder & Chairman (Age 51)
  • Dr. Claus Bo Søndergaard Svendsen, CEO, Principal Financial Officer & Member of Exec. Board (Age 43)
  • Mr. Thomas Carbone, Principal Accounting Officer (Age 63)

What is Forward Pharma A/S's stock symbol?

Forward Pharma A/S trades on the NASDAQ under the ticker symbol "FWP."

How do I buy shares of Forward Pharma A/S?

Shares of FWP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Forward Pharma A/S's stock price today?

One share of FWP stock can currently be purchased for approximately $6.58.

How big of a company is Forward Pharma A/S?

Forward Pharma A/S has a market capitalization of $44.68 million. Forward Pharma A/S employs 5 workers across the globe.

What is Forward Pharma A/S's official website?

The official website for Forward Pharma A/S is www.forward-pharma.com.

How can I contact Forward Pharma A/S?

Forward Pharma A/S's mailing address is OSTERGADE 24A 1, COPENHAGEN G7, 1100. The biotechnology company can be reached via phone at 0114533444242 or via email at [email protected]

This page was last updated on 1/21/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.